TIM-3 also have a higher expression, together with other checkpoint receptors, like PD-1, on T cells of AML patients as compared to healthy adults (23), and this is believed to be associated with severe T cell exhaustion and disease progression (10). Here, HAVCR2 is linked to acute myeloid leukemia.